Avior Wealth Management’s Revolution Medicines RVMD Stock Holding History

Avior Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$331K	Sell	1,769 -1,558	-47%	-$228K	0.01%	631
2026 Q1	$324K	Sell	3,327 -3,998	-55%	-$404K	0.01%	665
2025 Q4	$583K	Sell	7,325 -1,173	-14%	-$76.9K	0.02%	427
2025 Q3	$397K	Buy	+8,498	New	+$333K	0.01%	511
2024 Q2	–	Sell	-27	Closed	-$870	–	3434
2024 Q1	$870	Buy	+27	New	+$800	﹤0.01%	2431

Other funds holding RVMD

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

WPC

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

SCA

Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

CPM

Connective Portfolio Management New York $60.1M AUM 88.93% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Avior Wealth Management's RVMD Position: Q2 2026 in Review

Avior Wealth Management reduced its Revolution Medicines (RVMD) stake by 47% in Q2 2026, selling an estimated $228K and leaving 1,769 shares worth $331K. The position accounts for 0.01% of the portfolio, ranked #631.

Avior Wealth Management first reported a position in RVMD in Q1 2024 and has held it in 5 quarters since. The position peaked at $583K in Q4 2025. 64 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Avior Wealth Management held 1,769 shares of Revolution Medicines worth $331K as of Q2 2026.
Avior Wealth Management sold 1,558 Revolution Medicines shares in Q2 2026, an estimated $228K.
Revolution Medicines made up 0.01% of Avior Wealth Management's portfolio in Q2 2026, its #631 holding.
Avior Wealth Management first reported a position in Revolution Medicines in Q1 2024 and has held it in 5 quarters since.
Avior Wealth Management's Revolution Medicines position peaked at $583K in Q4 2025.
64 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.